Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Theurer

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
European Journal of Endocrinology|December 23, 2025
Real-world efficacy and safety of selpercatinib in RET-mutant medullary thyroid cancer at a Tertiary Referral CenterYara Maria Machlah, Lynn Marlene Srasra, Sarah Theurer, et al.
Indian Journal of Surgical Oncology|December 7, 2020
Differentiating Benign from Malignant Adrenocortical Tumors by a Single Morphological Parameter-a Clinicopathological Study on 837 Adrenocortical NeoplasiasMartin K Walz, Klaus A Metz, Sarah Theurer, et al.
Endocrine-Related Cancer|August 1, 2025
Lenvatinib as salvage therapy in advanced and progressive GI-NETAnnie Mathew, Jaume Capdevila, Nicole Unger, et al.
Frontiers in Endocrinology|October 18, 2021
Continued Discontinuation of TKI Treatment in Medullary Thyroid Carcinoma - Lessons From Individual Cases With Long-Term Follow-UpTim Brandenburg, Vera Tiedje, Philipp Muchalla, et al.
Endocrine-Related Cancer|January 16, 2026
Real-world data show limited efficacy of sequential cabozantinib treatment in RAIR-(P)DTCYara Maria Machlah, Lynn Marlene Srasra, Sarah Theurer, et al.
Pathology, Research and Practice|September 26, 2025
A subgroup of anaplastic thyroid carcinomas harbors MET alterations with potential therapeutic optionsSarah Theurer, Hans-Ulrich Schildhaus, Thomas Herold, et al.
Surgery|October 11, 2023
Sporadic noninvasive medullary thyroid neoplasm: A desmoplasia-negative unifocal nonmetastatic tumor cured by hemithyroidectomyHenning Dralle, Tim Brandenburg, Frank Weber, et al.
Frontiers in Immunology|May 29, 2024
Case report: Durable complete response of a mucosal melanoma of the rectum after neoadjuvant immunotherapy with ipilimumab plus nivolumabOskar Krueger, Robin Eisenburger, Alpaslan Tasdogan, et al.
The Journal of Clinical Endocrinology and Metabolism|May 23, 2025
Comprehensive Assessment of Multikinase Inhibitor Therapy Outcomes in RAIR-(P)DTC and MTC at a Tertiary Referral CenterYara Maria Machlah, Tim Brandenburg, Philipp Muchalla, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 26, 2023
Molecular Markers Are Associated with Onset of Radioiodine Refractoriness in Patients with Papillary Thyroid CarcinomaChristina Laschinsky, Sarah Theurer, Thomas Herold, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
European Journal of Endocrinology|December 23, 2025
Real-world efficacy and safety of selpercatinib in RET-mutant medullary thyroid cancer at a Tertiary Referral CenterYara Maria Machlah, Lynn Marlene Srasra, Sarah Theurer, et al.
Indian Journal of Surgical Oncology|December 7, 2020
Differentiating Benign from Malignant Adrenocortical Tumors by a Single Morphological Parameter-a Clinicopathological Study on 837 Adrenocortical NeoplasiasMartin K Walz, Klaus A Metz, Sarah Theurer, et al.
Endocrine-Related Cancer|August 1, 2025
Lenvatinib as salvage therapy in advanced and progressive GI-NETAnnie Mathew, Jaume Capdevila, Nicole Unger, et al.
Frontiers in Endocrinology|October 18, 2021
Continued Discontinuation of TKI Treatment in Medullary Thyroid Carcinoma - Lessons From Individual Cases With Long-Term Follow-UpTim Brandenburg, Vera Tiedje, Philipp Muchalla, et al.
Endocrine-Related Cancer|January 16, 2026
Real-world data show limited efficacy of sequential cabozantinib treatment in RAIR-(P)DTCYara Maria Machlah, Lynn Marlene Srasra, Sarah Theurer, et al.
Pathology, Research and Practice|September 26, 2025
A subgroup of anaplastic thyroid carcinomas harbors MET alterations with potential therapeutic optionsSarah Theurer, Hans-Ulrich Schildhaus, Thomas Herold, et al.
Surgery|October 11, 2023
Sporadic noninvasive medullary thyroid neoplasm: A desmoplasia-negative unifocal nonmetastatic tumor cured by hemithyroidectomyHenning Dralle, Tim Brandenburg, Frank Weber, et al.
Frontiers in Immunology|May 29, 2024
Case report: Durable complete response of a mucosal melanoma of the rectum after neoadjuvant immunotherapy with ipilimumab plus nivolumabOskar Krueger, Robin Eisenburger, Alpaslan Tasdogan, et al.
The Journal of Clinical Endocrinology and Metabolism|May 23, 2025
Comprehensive Assessment of Multikinase Inhibitor Therapy Outcomes in RAIR-(P)DTC and MTC at a Tertiary Referral CenterYara Maria Machlah, Tim Brandenburg, Philipp Muchalla, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 26, 2023
Molecular Markers Are Associated with Onset of Radioiodine Refractoriness in Patients with Papillary Thyroid CarcinomaChristina Laschinsky, Sarah Theurer, Thomas Herold, et al.
Pageof 5